Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Cash on Hand 2011-2025 | SIGA

Siga Technologies cash on hand from 2011 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Siga Technologies Annual Cash on Hand
(Millions of US $)
2024 $155
2023 $150
2022 $99
2021 $103
2020 $118
2019 $161
2018 $112
2017 $31
2016 $39
2015 $113
2014 $104
2013 $91
2012 $32
2011 $49
2010 $21
Siga Technologies Quarterly Cash on Hand
(Millions of US $)
2025-06-30 $182
2025-03-31 $162
2024-12-31 $155
2024-09-30 $99
2024-06-30 $107
2024-03-31 $144
2023-12-31 $150
2023-09-30 $71
2023-06-30 $76
2023-03-31 $116
2022-12-31 $99
2022-09-30 $110
2022-06-30 $115
2022-03-31 $153
2021-12-31 $103
2021-09-30 $93
2021-06-30 $98
2021-03-31 $107
2020-12-31 $118
2020-09-30 $79
2020-06-30 $53
2020-03-31 $77
2019-12-31 $161
2019-09-30 $89
2019-06-30 $112
2019-03-31 $114
2018-12-31 $112
2018-09-30 $108
2018-06-30 $22
2018-03-31 $25
2017-12-31 $31
2017-09-30 $36
2017-06-30 $41
2017-03-31 $40
2016-12-31 $39
2016-09-30 $20
2016-06-30 $78
2016-03-31 $104
2015-12-31 $113
2015-09-30 $129
2015-06-30 $116
2015-03-31 $96
2014-12-31 $104
2014-09-30 $105
2014-06-30 $99
2014-03-31 $107
2013-12-31 $91
2013-09-30 $105
2013-06-30 $33
2013-03-31 $25
2012-12-31 $32
2012-09-30 $23
2012-06-30 $35
2012-03-31 $43
2011-12-31 $49
2011-09-30 $12
2011-06-30 $15
2011-03-31 $19
2010-12-31 $21
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.604B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.69
Zoetis (ZTS) United States $53.099B 19.00
Takeda Pharmaceutical (TAK) Japan $43.243B 8.82
Daiichi Sankyo, - (DSNKY) Japan $42.092B 20.96
BeOne Medicines - (ONC) Switzerland $35.245B 0.00
Sandoz Group AG (SDZNY) Switzerland $29.520B 0.00
United Therapeutics (UTHR) United States $19.266B 16.95
Merck (MKKGY) Germany $16.414B 10.67
Neurocrine Biosciences (NBIX) United States $15.330B 36.78
Shionogi (SGIOY) Japan $14.275B 13.11
Summit Therapeutics (SMMT) United States $13.935B 0.00
Ionis Pharmaceuticals (IONS) United States $12.096B 0.00
IPSEN (IPSEY) France $12.095B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.808B 0.00
Orion OYJ (ORINY) Finland $9.208B 26.31
Eisai (ESAIY) $8.260B 0.00
Corcept Therapeutics (CORT) United States $8.063B 87.10
Stevanato Group S.p.A (STVN) Italy $7.571B 44.64
Grifols, S.A (GRFS) Spain $5.934B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.142B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.294B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.005B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.672B 17.45
Centessa Pharmaceuticals (CNTA) United Kingdom $3.016B 0.00
Dyne Therapeutics (DYN) United States $2.973B 0.00
Hypermarcas (HYPMY) Brazil $2.936B 22.07
Catalyst Pharmaceuticals (CPRX) United States $2.617B 8.38
Soleno Therapeutics (SLNO) United States $2.517B 0.00
Ocular Therapeutix (OCUL) United States $2.303B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.905B 22.58
Avadel Pharmaceuticals (AVDL) Ireland $1.841B 0.00
Guardian Pharmacy Services (GRDN) United States $1.836B 0.00
Xeris Biopharma Holdings (XERS) United States $1.594B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.510B 89.62
Ardelyx (ARDX) United States $1.446B 0.00
Harrow (HROW) United States $1.311B 0.00
Evotec AG (EVO) Germany $1.188B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.181B 0.00
Oruka Therapeutics (ORKA) United States $1.134B 0.00
Collegium Pharmaceutical (COLL) United States $1.129B 6.17
Relay Therapeutics (RLAY) United States $1.129B 0.00
Enliven Therapeutics (ELVN) United States $1.096B 0.00
Nektar Therapeutics (NKTR) United States $1.032B 0.00
Xencor (XNCR) United States $1.025B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
ARS Pharmaceuticals (SPRY) United States $0.894B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.753B 62.29
Savara (SVRA) United States $0.697B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.687B 6.13
Elite Pharmaceuticals (ELTP) United States $0.660B 0.00
Bioventus (BVS) United States $0.610B 12.51
Aquestive Therapeutics (AQST) United States $0.598B 0.00
Esperion Therapeutics (ESPR) United States $0.593B 0.00
Zevra Therapeutics (ZVRA) United States $0.565B 0.00
Akebia Therapeutics (AKBA) United States $0.562B 0.00
KalVista Pharmaceuticals (KALV) United States $0.555B 0.00
Organogenesis (ORGO) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.491B 0.00
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
USANA Health Sciences (USNA) United States $0.373B 10.41
Galectin Therapeutics (GALT) United States $0.363B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.335B 51.50
Altimmune (ALT) United States $0.331B 0.00
Lyell Immunopharma (LYEL) United States $0.318B 0.00
Korro Bio (KRRO) United States $0.304B 0.00
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.267B 0.00
Achieve Life Sciences (ACHV) Canada $0.252B 0.00
Nature's Sunshine Products (NATR) United States $0.249B 16.24
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.233B 0.00
AleAnna (ANNA) United States $0.217B 0.00
Avalo Therapeutics (AVTX) United States $0.216B 0.00
OmniAb (OABI) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Protara Therapeutics (TARA) United States $0.171B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.159B 0.00
Cassava Sciences (SAVA) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Surrozen (SRZN) United States $0.106B 0.00
Context Therapeutics (CNTX) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Avita Medical (RCEL) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.085B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.081B 0.00
Prelude Therapeutics (PRLD) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
VAXART, INC (VXRT) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
BioNxt Solutions (BNXTF) Canada $0.069B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Talphera (TLPH) United States $0.059B 0.00
Wellgistics Health (WGRX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
Plus Therapeutics (PSTV) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 29.12
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.022B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Ainos (AIMD) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Lipocine (LPCN) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00